Dr. Baoqing Li is a board certified radiation oncologist and Assistant Professor of Clinical Radiation Oncology at the Weill Cornell Medical College. After earning his Ph.D. in Molecular Biology from the University of Miami School of Medicine in 2000, Dr. Li received his M.D. at New York Medical College in 2005. He completed his residency training in Radiation Oncology at the University of California, Davis Cancer Center, Sacramento, California, where he was also Chief Resident from 2009-2010. In July 2010, Dr. Li joined the faculty of Radiation Oncology at the Weill Cornell Medical College and was appointed Assistant Professor in August 2011. Dr. Li has been full time Assistant Attending Physician at New York Hospital Queens, where he also serves as the Radiation Safety Champion. His clinical specialties are Head & Neck, Gastrointestinal, Lung, Breast, and Prostate Cancers. He has an extensive publication in both clinical and basic science research in first-tier peer-review journals. He is also actively involved in teaching and mentoring intern physicians, radiation oncology residents, and dental residents. Dr. Li received two prestigious awards from the ASCO Cancer Foundation and the American Radium Society.
A summary of Dr. Baoqing Li’s education, training, awards, and publications is listed as following:
Resident Physician 7/2006 to 6/2010
Departement of Radiation Oncology,
the University of California Davis Cancer Center
Intern Physician 7/2005 to 6/2006
Department of Internal Medicine
Flushing Hospital Medical Center
Flushing, New York
HONORS AND AWARDS
Name of award Date awarded
1) ASCO Cancer Foundation Merit Award 10/2010
from American Society of Clinical Oncology (ASCO)
2) Young Oncologist Award 5/2010
from American Radium Society
3) Prostate Cancer Brahcytherapy fellowship (Seattle Prostate Institute) 10/2009
from American Brachytherapy Society abd American Colege of Radiation oncology
4) Radiation Oncology Resident Award 2/2009
from American College of Radiation Oncology
5) Ph.D. Dissertation Merit Award 5/2000
from the University of Miami
6) Travel Award 4/2005
from American Medical Association (AMA)
the 30th AMA Medical Student Research Forum
Member/officer Name of Organization Dates held
Member, American Radium Society,
5/1/2008 to present
Member, American College of Radiation Oncology (ACRO)
Member, American Society of Radiation Oncology (ASTRO)
7/1/2006 to present
Member, American Association for Cancer Research (AACR)
1/1/1997 to present
INVITED JOURNAL REVIEWER
International Journal of Radiation Oncology, Biology, and Physics
“New Radiation Techniques in the Treatment of Rectal Cancer”. Gastrointestinal Cancers: Update 2011. Columbia University Medical Center GME course, Oct. 2011.
“SBRT for inoperable early stage lung cancer”. NYHQ Lung Cancer Symposium, Nov. 2012
“Chemotherapy and Survival in Nasopharyngeal Cancer in Asian-Americans”. 6th Annual World Cancer Congress-2013, Xi’an, China, May 2013
SELECTED PUBLICATIONS (PEER-REVIEWED, ORIGINAL RESEARCH ARTICLES)
1: Stessin AM, Sison C, Schwartz A, Ng J, KSC Chao, Li B.
Does adjuvant radiotherapy benefit patients with diffuse-type gastric cancer? Results from teh Surveilliance, Epidemiology, and End Result (SEER) dtatbase.
Cancer. 2014 Jul 15 (Epub ahead of print)
2: Stessin AM, Sison C, Nieto J, Raifu M, Li B.
The role of postoperative radiation therapy in the treatment of meningeal hemangiopericytoma-experience from the SEER database.
Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):784-90.
3: Li B, Chen M, Nori D, Chao KS, Chen AM, Chen SL.
Adjuvant radiation therapy and survival for pure tubular breast carcinoma--experience from the SEER database.
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):23-9.
4: Chen AM, Farwell DG, Lau DH, Li BQ, Luu Q, Donald PJ.
Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?
Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):346-52.
5: Li B, Shi XB, Nori D, Chao CK, Chen AM, Valicenti R, White de V.
Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells.
Prostate. 2011 May;71(6):567-74.
6: Chen AM, Hall WH, Li BQ, Guiou M, Wright C, Mathai M, Dublin A, Purdy JA.
Intensity-modulated radiotherapy increases dose to the brachial plexus compared with conventional radiotherapy for head and neck cancer.
Br J Radiol. 2011 Jan;84(997):58-63.
7: Li B, Bobinski M, Gandour-Edwards R, Farwell DG, Chen AM.
Overstaging of cartilage invasion by multidetector CT scan for laryngeal cancer and its potential effect on the use of organ preservation with chemoradiation.
Br J Radiol. 2011 Jan;84(997):64-9.
8: Chen AM, Li BQ, Farwell DG, Marsano J, Vijayakumar S, Purdy JA.
Improved dosimetric and clinical outcomes with intensity-modulated radiotherapy for head-and-neck cancer of unknown primary origin.
Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):756-62.
9: Chen AM, Li BQ, Lau DH, Farwell DG, Luu Q, Stuart K, Newman K, Purdy JA, Vijayakumar S.
Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer.
Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1026-32.
10: Li B, Li D, Lau DH, Farwell DG, Luu Q, Rocke DM, Newman K, Courquin J, Purdy JA, Chen AM.
Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy.
Radiat Oncol. 2009 Nov 12;4:52.
11: Chen AM, Li BQ, Jennelle RL, Lau DH, Yang CC, Courquin J, Vijayakumar S, Purdy JA.
Late esophageal toxicity after radiation therapy for head and neck cancer.
Head Neck. 2010 Feb;32(2):178-83.
12: Yang GY, Li B, Wagner TD, Donohue KA, Flaherty L, Kuettel MR.
Long-term outcome of stage I seminoma.
Am J Clin Oncol. 2007 Apr;30(2):205-10.
13: Li B, Lee MY.
Transcriptional regulation of the human DNA polymerase delta
catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1.
J Biol Chem. 2001 Aug 10;276(32):29729-39.
14: Wu SM, Zhang P, Zeng XR, Zhang SJ, Mo J, Li BQ, Lee MY.
Characterization of the p125 subunit of human DNA polymerase delta and its deletion mutants. Interaction with cyclin-dependent kinase-cyclins.
J Biol Chem. 1998 Apr 17;273(16):9561-9.
15: Sun Y, Jiang Y, Zhang P, Zhang SJ, Zhou Y, Li BQ, Toomey NL, Lee MY.
Expression and characterization of the small subunit of human DNA polymerase delta.
J Biol Chem. 1997 May 16;272(20):13013-8.